Chevron Corporation (CVX) Stock Forecast
Data as of Oct 31, 2026Energy · Current price $235.21 (+1.62%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 17, 2026 | Lucas Herrmann | BNP Paribas | $174.00 | -26.0% |
| Mar 27, 2026 | Devin McDermott | Morgan Stanley | $212.00 | -9.9% |
| Jan 21, 2026 | Betty Jiang | Barclays | $166.00 | -29.4% |
| Jan 14, 2026 | Lloyd Byrne | Jefferies | $189.00 | -19.6% |
| Jan 8, 2026 | Ryan Todd | Piper Sandler | $174.00 | -26.0% |
| Oct 7, 2025 | Betty Jiang | Barclays | $158.00 | -32.8% |
| Sep 15, 2025 | Nitin Kumar | Mizuho Securities | $191.00 | -18.8% |
| Aug 1, 2025 | Roger Read | Wells Fargo | $178.00 | -24.3% |
| Apr 15, 2025 | Lucas Herrmann | BNP Paribas | $140.00 | -40.5% |
| Dec 9, 2024 | Ryan Todd | Piper Sandler | $184.00 | -21.8% |
| Nov 4, 2024 | Neal Dingmann | Truist Financial | $155.00 | -34.1% |
| Oct 21, 2024 | Neal Dingmann | Truist Financial | $150.00 | -36.2% |
| Oct 17, 2024 | Jean Ann Salisbury | Bank of America Securities | $168.00 | -28.6% |
| Oct 10, 2024 | Paul Cheng | Scotiabank | $163.00 | -30.7% |
| Oct 2, 2024 | Betty Jiang | Barclays | $168.00 | -28.6% |
| Aug 6, 2024 | Betty Jiang | Barclays | $185.00 | -21.3% |
| Aug 5, 2024 | Neal Dingmann | Truist Financial | $154.00 | -34.5% |
| Aug 5, 2024 | Neil Mehta | Goldman Sachs | $177.00 | -24.7% |
| Aug 5, 2024 | Biraj Borkhataria | RBC Capital | $180.00 | -23.5% |
| Aug 2, 2024 | Bob Brackett | Bernstein | $138.00 | -41.3% |
Top Analysts Covering CVX
CVX vs Sector & Market
| Metric | CVX | Energy Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.42 | 2.47 | 2.41 |
| Analyst Count | 24 | 9 | 19 |
| Target Upside | -9.0% | +115.5% | +21.5% |
| P/E Ratio | 40.76 | 34.68 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $195.58B | $225.48B | $276.10B | 11 |
| 2027-12-31 | $190.15B | $209.44B | $236.92B | 11 |
| 2028-12-31 | $209.40B | $211.50B | $213.59B | 11 |
| 2029-03-31 | $44.51B | $57.31B | $78.21B | 5 |
| 2029-06-30 | $45.28B | $58.31B | $79.58B | 4 |
| 2029-09-30 | $46.07B | $59.32B | $80.96B | 4 |
| 2029-12-31 | $46.87B | $60.35B | $82.37B | 5 |
| 2030-03-31 | $47.69B | $61.41B | $83.81B | 3 |
| 2030-06-30 | $48.52B | $62.48B | $85.27B | 3 |
| 2030-09-30 | $49.37B | $63.56B | $86.75B | 3 |
| 2030-12-31 | $50.23B | $64.67B | $88.26B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.57 | $12.15 | $15.97 | 14 |
| 2027-12-31 | $6.48 | $11.27 | $16.50 | 14 |
| 2028-12-31 | $8.85 | $12.02 | $17.83 | 6 |
| 2029-03-31 | $2.61 | $3.68 | $5.43 | 5 |
| 2029-06-30 | $3.24 | $4.56 | $6.72 | 7 |
| 2029-09-30 | $3.70 | $5.22 | $7.70 | 4 |
| 2029-12-31 | $3.49 | $4.92 | $7.25 | 4 |
| 2030-03-31 | $2.82 | $3.97 | $5.85 | 6 |
| 2030-06-30 | $3.51 | $4.94 | $7.28 | 8 |
| 2030-09-30 | $4.05 | $5.71 | $8.42 | 4 |
| 2030-12-31 | $3.82 | $5.38 | $7.93 | 4 |
Frequently Asked Questions
What is the analyst consensus for CVX?
The consensus among 24 analysts covering Chevron Corporation (CVX) is Buy with an average price target of $216.92.
What is the highest price target for CVX?
The highest price target for CVX is $212.00, set by Devin McDermott at Morgan Stanley on 2026-03-27.
What is the lowest price target for CVX?
The lowest price target for CVX is $87.00, set by Edward Kelly at Wells Fargo on 2023-01-09.
How many analysts cover CVX?
24 analysts have issued ratings for Chevron Corporation in the past 12 months.
Is CVX a buy or sell right now?
Based on 24 analyst ratings, CVX has a consensus rating of Buy (2.42/5) with a -9.0% upside to the consensus target of $216.92.
What are the earnings estimates for CVX?
Analysts estimate CVX will report EPS of $12.15 for the period ending 2026-12-31, with revenue estimated at $225.48B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.